Renaissance Technologies’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-243,484
Closed -$2.89M 3752
2024
Q1
$2.89M Buy
243,484
+201,184
+476% +$2.39M ﹤0.01% 1790
2023
Q4
$518K Sell
42,300
-26,800
-39% -$328K ﹤0.01% 2750
2023
Q3
$665K Sell
69,100
-73,828
-52% -$711K ﹤0.01% 2570
2023
Q2
$1.29M Buy
142,928
+62,328
+77% +$561K ﹤0.01% 2310
2023
Q1
$634K Sell
80,600
-13,700
-15% -$108K ﹤0.01% 2756
2022
Q4
$637K Sell
94,300
-29,800
-24% -$201K ﹤0.01% 2804
2022
Q3
$1.8M Sell
124,100
-105,270
-46% -$1.53M ﹤0.01% 2081
2022
Q2
$2.26M Buy
229,370
+212,570
+1,265% +$2.09M ﹤0.01% 2103
2022
Q1
$248K Sell
16,800
-5,627
-25% -$83.1K ﹤0.01% 3552
2021
Q4
$297K Sell
22,427
-1,101
-5% -$14.6K ﹤0.01% 3347
2021
Q3
$411K Buy
+23,528
New +$411K ﹤0.01% 2960
2021
Q2
Sell
-153,428
Closed -$3.94M 3633
2021
Q1
$3.94M Buy
153,428
+104,000
+210% +$2.67M ﹤0.01% 1800
2020
Q4
$939K Buy
+49,428
New +$939K ﹤0.01% 2528
2020
Q3
Sell
-41,346
Closed -$500K 3524
2020
Q2
$500K Sell
41,346
-6,182
-13% -$74.8K ﹤0.01% 2876
2020
Q1
$364K Buy
+47,528
New +$364K ﹤0.01% 2900
2019
Q4
Sell
-19,028
Closed -$221K 3627
2019
Q3
$221K Buy
+19,028
New +$221K ﹤0.01% 3119
2019
Q2
Sell
-159,929
Closed -$4.58M 3655
2019
Q1
$4.58M Sell
159,929
-19,300
-11% -$552K ﹤0.01% 1859
2018
Q4
$3.54M Buy
179,229
+61,880
+53% +$1.22M ﹤0.01% 1948
2018
Q3
$2.6M Buy
117,349
+81,621
+228% +$1.8M ﹤0.01% 2154
2018
Q2
$290K Sell
35,728
-7,700
-18% -$62.5K ﹤0.01% 2973
2018
Q1
$412K Sell
43,428
-45,300
-51% -$430K ﹤0.01% 2972
2017
Q4
$865K Buy
+88,728
New +$865K ﹤0.01% 2721
2016
Q4
Sell
-17,337
Closed -$112K 3350
2016
Q3
$112K Buy
+17,337
New +$112K ﹤0.01% 3164